Prudential Financial Inc. boosted its position in shares of Medical Properties Trust, Inc. (NYSE:MPW) by 766.7% during the second quarter, according to its most recent disclosure with the SEC. The institutional investor owned 4,320,798 shares of the real estate investment trust’s stock after buying an additional 3,822,244 shares during the period. Prudential Financial Inc. owned 1.19% of Medical Properties Trust worth $55,608,000 as of its most recent SEC filing.

A number of other hedge funds have also recently made changes to their positions in MPW. IFP Advisors Inc boosted its stake in shares of Medical Properties Trust by 15.1% in the first quarter. IFP Advisors Inc now owns 9,009 shares of the real estate investment trust’s stock worth $116,000 after buying an additional 1,182 shares in the last quarter. Blair William & Co. IL purchased a new stake in shares of Medical Properties Trust during the second quarter worth approximately $132,000. Neuburgh Advisers LLC boosted its stake in shares of Medical Properties Trust by 6.2% in the first quarter. Neuburgh Advisers LLC now owns 10,582 shares of the real estate investment trust’s stock worth $136,000 after buying an additional 616 shares in the last quarter. Cutter & CO Brokerage Inc. boosted its stake in shares of Medical Properties Trust by 10.3% in the second quarter. Cutter & CO Brokerage Inc. now owns 11,081 shares of the real estate investment trust’s stock worth $143,000 after buying an additional 1,031 shares in the last quarter. Finally, Huntington National Bank boosted its stake in shares of Medical Properties Trust by 70.1% in the first quarter. Huntington National Bank now owns 11,434 shares of the real estate investment trust’s stock worth $147,000 after buying an additional 4,712 shares in the last quarter. Hedge funds and other institutional investors own 85.55% of the company’s stock.

Medical Properties Trust, Inc. (NYSE MPW) opened at 12.81 on Tuesday. The stock has a 50 day moving average of $12.75 and a 200 day moving average of $13.03. Medical Properties Trust, Inc. has a 12 month low of $11.54 and a 12 month high of $15.57. The company has a market capitalization of $4.48 billion, a price-to-earnings ratio of 15.66 and a beta of 0.89.

Medical Properties Trust (NYSE:MPW) last released its quarterly earnings data on Wednesday, August 9th. The real estate investment trust reported $0.32 EPS for the quarter, hitting the consensus estimate of $0.32. Medical Properties Trust had a return on equity of 7.54% and a net margin of 42.25%. The company had revenue of $166.80 million during the quarter, compared to the consensus estimate of $163.08 million. During the same period last year, the company earned $0.32 EPS. Medical Properties Trust’s revenue for the quarter was up 32.1% on a year-over-year basis. Equities analysts anticipate that Medical Properties Trust, Inc. will post $0.86 EPS for the current fiscal year.

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, October 12th. Investors of record on Thursday, September 14th will be issued a $0.24 dividend. The ex-dividend date is Wednesday, September 13th. This represents a $0.96 annualized dividend and a yield of 7.49%. Medical Properties Trust’s payout ratio is 115.66%.

ILLEGAL ACTIVITY WARNING: “Medical Properties Trust, Inc. (MPW) Position Boosted by Prudential Financial Inc.” was posted by Watch List News and is owned by of Watch List News. If you are viewing this report on another publication, it was stolen and republished in violation of United States & international copyright and trademark laws. The correct version of this report can be viewed at https://www.watchlistnews.com/medical-properties-trust-inc-mpw-position-boosted-by-prudential-financial-inc/1529410.html.

MPW has been the subject of a number of recent analyst reports. Zacks Investment Research upgraded shares of Medical Properties Trust from a “hold” rating to a “buy” rating and set a $15.00 price target for the company in a research note on Wednesday, July 19th. Royal Bank Of Canada reiterated a “buy” rating and issued a $16.00 price target on shares of Medical Properties Trust in a research note on Monday, July 24th. Jefferies Group LLC reiterated a “buy” rating and issued a $16.00 price target (up previously from $15.00) on shares of Medical Properties Trust in a research note on Friday, June 9th. Deutsche Bank AG increased their price target on shares of Medical Properties Trust from $13.50 to $15.00 and gave the company a “buy” rating in a research note on Tuesday, July 4th. Finally, ValuEngine upgraded shares of Medical Properties Trust from a “hold” rating to a “buy” rating in a research note on Thursday, August 3rd. Two investment analysts have rated the stock with a sell rating, six have assigned a hold rating and seven have assigned a buy rating to the company. Medical Properties Trust has an average rating of “Hold” and a consensus target price of $14.20.

In related news, CFO R Steven Hamner sold 85,000 shares of Medical Properties Trust stock in a transaction dated Wednesday, June 14th. The stock was sold at an average price of $13.36, for a total value of $1,135,600.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 1.00% of the stock is currently owned by company insiders.

Medical Properties Trust Company Profile

Medical Properties Trust, Inc is a real estate investment trust (REIT). The Company focuses on investing in and owning net-leased healthcare facilities across the United States and selectively in foreign jurisdictions. The Company’s segment is its investments in healthcare real estate, including mortgage and other loans, as well as any equity investments in its tenants.

Institutional Ownership by Quarter for Medical Properties Trust (NYSE:MPW)

Receive News & Ratings for Medical Properties Trust Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medical Properties Trust Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.